Tarnagulla Ventures

Tarnagulla Ventures invests in seed and venture capital for healthcare companies. They have made 3 investments, including Inversago Pharma in Series A on July...

Tarnagulla Ventures

Tarnagulla Ventures invests in seed and venture capital for healthcare companies. They have made 3 investments, including Inversago Pharma in Series A on July 25, 2018. Tarnagulla Ventures has 2 portfolio exits, with Jupiter Neurosciences being their latest on December 03, 2024.

Website

tarnagullaventures.com

linkedin.com/company/tarnagulla-ventures

General information

Firm type

Venture Capital

Year founded

2015

Location

Region

Oceania

Country

Australia

City

South Yarra

Corporate office

South Yarra, VIC, Australia

What investment stages does Tarnagulla Ventures target?

Tarnagulla Ventures concentrates on early-stage investments, specifically seed and early-stage venture rounds. The firm's stated strategy covers inception-level backing for Australian startups. No growth-equity or later-stage activity has been disclosed in its public materials.

Where does Tarnagulla Ventures invest geographically?

The firm is headquartered in South Yarra, Victoria, and its strategy is focused on Australian companies. No international offices, cross-border mandates, or offshore portfolio exposures have been identified in available records. The firm's name and location suggest a concentrated domestic orientation.

Does Tarnagulla Ventures invest directly or via funds?

Tarnagulla Ventures operates as a direct investor in early-stage companies rather than as a fund-of-funds. Public information points to the firm taking equity positions in seed rounds directly, without any disclosed limited-partner commitments to external venture fund managers.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Jun 3, 2026. Continuous refresh with full update cycles at least every 30 days.